Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Phillip H. Lam"'
Autor:
Tran Nguyen, Phillip H. Lam, Gerasimos Filippatos, Samuel Wopperer, Ali Ahmed, Cherinne Arundel, Charles Faselis, Samir S. Patel, Gregg C. Fonarow, Prakash Deedwania, Richard M. Allman, Michael R. Zile
Publikováno v:
The American Journal of Medicine. 134:797-804
The effect of loop diuretics on clinical outcomes in heart failure has not been evaluated in randomized controlled trials. In hospitalized patients with heart failure, a discharge loop diuretic prescription has been shown to be associated with improv
Autor:
Phillip H. Lam, Prakash Deedwania, Michael R. Zile, Wilbert S. Aronow, Poonam Bhyan, Charles Faselis, Richard M. Allman, Apostolos Tsimploulis, Charity J. Morgan, Samir S. Patel, Cherinne Arundel, Deepak L. Bhatt, Qing Zeng-Trietler, Ali Ahmed, Gregg C. Fonarow, Peter Kokkinos
Publikováno v:
Am J Med
BACKGROUND: New hypertension and heart failure guidelines recommend that systolic blood pressure (SBP) in patients with heart failure with preserved ejection fraction (HFpEF) and hypertension be lowered to
Autor:
Vijaywant Brar, Phillip H. Lam, Farooq H. Sheikh, Nitin Malik, Patrick T Bering, Cyrus Hadadi, Manavotam Singh
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:862-866
Sustained ventricular tachycardia and ventricular fibrillation (VF) are life-threatening arrhythmias which remain highly prevalent in patients with advanced heart failure. These ventricular arrhythmias may impair the support provided by continuous-fl
Autor:
Charity J. Morgan, Hans Moore, Markus S. Anker, Cherinne Arundel, Prakash Deedwania, Richard M. Allman, Samuel Wopperer, Steven N. Singh, Charles Faselis, Gregg C. Fonarow, Qing Zeng, Phillip H. Lam, Lakshmi Tummala, Pamela Karasik, Ali Ahmed
Publikováno v:
The American Journal of Medicine. 133:1460-1470
Background Digoxin reduces the risk of heart failure hospitalization but has no effect on mortality in patients with heart failure without atrial fibrillation in the randomized controlled trial setting. Observational studies of digoxin use in patient
Autor:
Cherinne Arundel, Milton Packer, Steven N. Singh, Yan Cheng, Wayne C. Levy, Richard M. Allman, Vijaywant Brar, Wen-Chih Wu, Gregg C. Fonarow, Phillip H. Lam, Michael R. Zile, Ali Ahmed, Gauravpal S. Gill
Publikováno v:
The American Journal of Medicine. 133:1187-1194
Background Digoxin reduces the risk of heart failure hospitalization in patients with heart failure with reduced ejection fraction. Less is known about this association in patients with heart failure with preserved ejection fraction (HFpEF), the exam
Autor:
Cherinne Arundel, Charles Faselis, Phillip H. Lam, Selma F. Mohammed, Charity J. Morgan, Linda G. Jones, Gregg C. Fonarow, Richard M. Allman, Helen Sheriff, Corrine Y. Jurgens, Ali Ahmed
Publikováno v:
American Journal of Therapeutics. 27:e235-e242
Background Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs-ARBs) improve outcomes in heart failure (HF). Less is known about this association in nursing home (NH) residents. Methods Of the 8024 hospitalized HF patient
Publikováno v:
Trends in Cardiovascular Medicine. 30:223-229
Early generation left ventricular assist devices (LVAD) for treatment of refractory heart failure attempted to mimic the pulsatility of a native heart and were bulky and less durable due to valves within the inflow and outflow pathways. The next disr
Autor:
Bertram Pitt, Prakash Deedwania, Gregg C. Fonarow, Ali Ahmed, Charity J. Morgan, Deepak L. Bhatt, Neha Gupta, Steven N. Singh, Michael R. Zile, Phillip H. Lam, Daniel J. Dooley
Publikováno v:
The American Journal of Medicine. 131:1473-1481
Background Beta-blockers in high target doses are recommended for heart failure with reduced ejection fraction (HFrEF) but not for preserved ejection fraction (HFpEF). Treatment benefits are often more pronounced in high-risk subgroups, and patients
Autor:
Cherinne Arundel, Wilbert S. Aronow, Helen Sheriff, Ali Ahmed, Gregg C. Fonarow, Richard M. Allman, Finn Waagstein, Poonam Bhyan, Phillip H. Lam, Charity J. Morgan, Daniel J. Dooley, Selma F. Mohammed
Publikováno v:
Clinical Cardiology. 41:406-412
BACKGROUND: Digoxin use has been associated with a lower risk of 30‐day all‐cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF). HYPOTHESIS: Digoxin use will be associated with improved outcomes in
Autor:
Marc R. Blackman, Stefan D. Anker, Wilbert S. Aronow, Daniel E. Forman, Inmaculada Aban, Javed Butler, Ioannis Kanonidis, Phillip H. Lam, Deepak L. Bhatt, Prakash Deedwania, Chris Adamopoulos, Daniel J. Dooley, Gerasimos Filippatos, Bertram Pitt, Ross D. Fletcher, Gregg C. Fonarow, Kanan Patel, Michel White, Richard M. Allman, Cherinne Arundel, Ali Ahmed
Publikováno v:
European Journal of Heart Failure. 20:359-369
Aims To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunc